Labetalol Infusion for Managing Acute Hypertension
The recommended dosing regimen for labetalol infusion in managing acute hypertension is to prepare a solution by diluting 200 mg labetalol in 160-250 mL of compatible IV fluid (1 mg/mL or 2 mg/3 mL concentration) and administer at an initial rate of 2 mg/minute, adjusting according to blood pressure response with an effective dose range of 50-200 mg (maximum 300 mg). 1
Preparation Methods
Continuous Infusion Preparation
- Dilute 40 mL of labetalol (200 mg) with 160 mL of compatible IV fluid to create a 1 mg/mL solution 1
- Alternatively, dilute 40 mL of labetalol (200 mg) with 250 mL of compatible IV fluid to create a 2 mg/3 mL solution 1
- Compatible IV fluids include Ringer's Injection, Lactated Ringer's, 5% Dextrose, 0.9% Sodium Chloride, and various combinations 1
- NOT compatible with 5% Sodium Bicarbonate Injection 1
Administration Rate
- Initial infusion rate: 2 mg/minute 1
- Adjust rate according to blood pressure response 1
- Effective dose range: 50-200 mg (total dose up to 300 mg may be required in some patients) 1
Alternative Administration Method: Repeated IV Injections
- Initial dose: 20 mg (0.25 mg/kg for an 80 kg patient) by slow IV injection over 2 minutes 1
- Measure blood pressure before injection and at 5 and 10 minutes after injection 1
- Additional injections of 40 mg or 80 mg can be given at 10-minute intervals 1
- Maximum total dose: 300 mg 1
- Maximum effect usually occurs within 5 minutes of each injection 1
Blood Pressure Monitoring and Targets
- Monitor blood pressure during and after completion of infusion or IV injections 1
- Avoid rapid or excessive falls in either systolic or diastolic blood pressure 1
- For acute ischemic stroke: Target 10-15% reduction in blood pressure 2
- For acute hemorrhagic stroke: Target systolic BP <180 mmHg 2
- For patients eligible for thrombolytic therapy: Maintain BP <185/110 mmHg 2
- For severe pre-eclampsia/eclampsia: Target systolic BP <160 mmHg and diastolic BP <105 mmHg 2
Specific Clinical Scenarios
Acute Aortic Disease
- Labetalol is first-line treatment along with ultra-short acting vasodilators 3
- Target: Systolic BP ≤120 mmHg and heart rate ≤60 bpm 3
Acute Stroke
- For ischemic stroke with BP >220/120 mmHg: Labetalol 10-20 mg IV over 1-2 minutes 2
- For hemorrhagic stroke: Labetalol is drug of choice to lower BP to <180 mmHg 3
- Labetalol may be preferred in hypertensive encephalopathy as it leaves cerebral blood flow relatively intact 3, 2
Pre-eclampsia/Eclampsia
- First-line treatment for severe pre-eclampsia requiring IV therapy 3
- Cumulative dose should not exceed 800 mg/24h to prevent fetal bradycardia 3
Acute Coronary Events
- Labetalol can be used to lower BP in patients with acute coronary events 3
- Reduces afterload without increasing heart rate, decreasing myocardial oxygen demand 1
Contraindications and Precautions
- Contraindicated in patients with:
- Due to alpha1-receptor blocking activity, blood pressure is lowered more in standing than supine position 1
- Patients should not be allowed to move to an erect position unmonitored 1
- Prolonged administration requires vigilance due to risk of cardiovascular depression 4
Pharmacodynamics and Onset of Action
- Onset of action: 1-2 minutes 3
- Duration of action: 5-8 hours 1
- Produces dose-related falls in blood pressure without reflex tachycardia 1
- Acts through combined alpha and beta-adrenergic blockade 1
- Initial mini-bolus injection (20 mg) causes rapid but not abrupt reduction in blood pressure 5